Ionis to present at upcoming investor conferences
Ionis Pharmaceuticals (NASDAQ: IONS) has announced its participation in six major healthcare investor conferences throughout November and December 2024. The company's management will engage in fireside chats at events including Guggenheim's Inaugural Healthcare Conference, UBS Global Healthcare Conference, Stifel Healthcare Conference, Jefferies London Healthcare Conference, Citi's Global Healthcare Conference, and Piper Sandler Annual Healthcare Conference. Live webcasts will be available on the Ionis website's Investors & Media section, with replays accessible within 48 hours and archived for a time.
Ionis Pharmaceuticals (NASDAQ: IONS) ha annunciato la sua partecipazione a sei importanti conferenze per investitori nel settore sanitario nei mesi di novembre e dicembre 2024. La direzione dell'azienda parteciperà a conversazioni informali in eventi che includono la Conferenza Inaugurale sulla Salute di Guggenheim, la Conferenza Globale sulla Salute di UBS, la Conferenza sulla Salute di Stifel, la Conferenza Sanitaria di Jefferies a Londra, la Conferenza Globale sulla Salute di Citi e la Conferenza Annuale sulla Salute di Piper Sandler. Saranno disponibili webcast dal vivo nella sezione Investitori e Media del sito di Ionis, con repliche accessibili entro 48 ore e archiviate per un periodo di tempo.
Ionis Pharmaceuticals (NASDAQ: IONS) ha anunciado su participación en seis importantes conferencias para inversores en el ámbito de la salud durante noviembre y diciembre de 2024. La dirección de la empresa participará en charlas informales en eventos que incluyen la Conferencia Inaugural de Salud de Guggenheim, la Conferencia Global de Salud de UBS, la Conferencia de Salud de Stifel, la Conferencia de Salud de Jefferies en Londres, la Conferencia Global de Salud de Citi y la Conferencia Anual de Salud de Piper Sandler. Se ofrecerán transmisiones web en vivo en la sección de Inversores y Medios del sitio web de Ionis, con repeticiones accesibles dentro de las 48 horas y archivadas por un tiempo.
아이오니스 제약 (NASDAQ: IONS)는 2024년 11월과 12월에 걸쳐 6개의 주요 헬스케어 투자자 회의에 참여할 것이라고 발표했습니다. 회사 경영진은 구겐하임의 첫 헬스케어 회의, UBS 글로벌 헬스케어 회의, 스티펠 헬스케어 회의, 제프리의 런던 헬스케어 회의, 시티의 글로벌 헬스케어 회의, 파이퍼 샌들러 연례 헬스케어 회의 등 다양한 행사에서 대담에 참여할 예정입니다. 라이브 웹캐스트는 아이오니스 웹사이트의 투자자 및 미디어 섹션에서 제공되며, 48시간 이내에 다시보기와 함께 일정 기간 아카이브됩니다.
Ionis Pharmaceuticals (NASDAQ: IONS) a annoncé sa participation à six grandes conférences d'investisseurs dans le secteur de la santé au cours des mois de novembre et décembre 2024. La direction de l'entreprise participera à des discussions informelles lors d'événements, notamment la première conférence de santé de Guggenheim, la conférence mondiale de santé de UBS, la conférence de santé de Stifel, la conférence de santé de Jefferies à Londres, la conférence mondiale de santé de Citi et la conférence annuelle de santé de Piper Sandler. Des webdiffusions en direct seront disponibles dans la section Investisseurs et Médias du site web d'Ionis, avec des rediffusions accessibles dans les 48 heures et archivées pendant un certain temps.
Ionis Pharmaceuticals (NASDAQ: IONS) hat seine Teilnahme an sechs bedeutenden Investorenkonferenzen im Gesundheitswesen für November und Dezember 2024 angekündigt. Das Management des Unternehmens wird an informellen Gesprächen bei Veranstaltungen teilnehmen, die die erste Gesundheitskonferenz von Guggenheim, die UBS Global Healthcare Conference, die Stifel Healthcare Conference, die Jefferies London Healthcare Conference, die Citi Global Healthcare Conference und die Piper Sandler Annual Healthcare Conference umfassen. Live-Webcasts werden im Investor- und Medienbereich der Ionis-Website verfügbar sein, mit Wiederholungen, die innerhalb von 48 Stunden zugänglich sind und für eine gewisse Zeit archiviert werden.
- None.
- None.
- Guggenheim's Inaugural Healthcare Conference on Wednesday, November 13, 2024
- UBS Global Healthcare Conference on Wednesday, November 13, 2024
- Stifel 2024 Healthcare Conference on Monday, November 18, 2024
- Jefferies London Healthcare Conference on Wednesday, November 20, 2024
- Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024
- Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024
A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.
About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679
View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302297951.html
SOURCE Ionis Pharmaceuticals, Inc.
FAQ
What investor conferences will Ionis (IONS) attend in November 2024?
How can investors watch Ionis (IONS) conference presentations in 2024?
Which December 2024 healthcare conferences will Ionis (IONS) participate in?
